* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download HIV Attachment & Entry: Insights into pathogenesis and
Endomembrane system wikipedia , lookup
Cell nucleus wikipedia , lookup
Cell growth wikipedia , lookup
Cell culture wikipedia , lookup
Cytokinesis wikipedia , lookup
Cell encapsulation wikipedia , lookup
Biochemical switches in the cell cycle wikipedia , lookup
Signal transduction wikipedia , lookup
Cellular differentiation wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
HIV Cellular Pathogenesis II Benhur Lee, M.D. HIV Accessory Genes: Tat Rev Essential in vitro and in vivo Vif Essential in certain cell types (Permissive vs Non-permissive cells) Vpr Vpu Nef Non-essential in vitro, but leads to attenuated phenotype in vivo Tat: Transactivator of HIV’s LTR Promoter – Binding of Tat to TAR in vitro does NOT require loop sequences known to be necessary in vivo for function – Pre-incubation of nuclear extracts with recombinant Tat depletes a factor necessary for Tat-mediated transcription in vitro – Tat functions poorly in rodent cells unless complemented by factor(s) present on Chromosome 12 (radiation hybrids) – Tat associates with a kinase complex that hyperphosphorylates CTD of RNAP II (identified thru an in vitro drug screen for Tat inhibitors)--this kinase is Cdk9, but Cdk9 does NOT bind Tat!? – Mystery human-specific co-factor for Tat activity must exist 2º structure of HIV TAR sequence “bulge” • Experimental Observations: “loop” Predicted and confirmed properties of Tat co-factor: Cyclin T Binds directly to Tat in a complex with Cdk9 Increases the affinity of Tat for TAR Increases the specificity of Tat for “loop” and “bulge” residues Tat-CycT-Cdk9 complex hyperphosphorylates CTD of RNAP II and increases HIV transcriptional processivity CycT maps to chromosome 12, and potentiates Tat trans-activation in murine cells 50- to 100- fold Murine homolog of human CycT does NOT bind to Tat Tat: Transactivator of HIV’s LTR Promoter • Experimental Observations Explained: – Binding of Tat to TAR in vitro does NOT require loop sequences known to be necessary in vivo for function – Pre-incubation of nuclear extracts with recombinant Tat depletes a factor necessary for Tat-mediated transcription in vitro – Tat functions poorly in rodent cells unless complemented by factor(s) present on Chromosome 12 (radiation hybrids) – Tat associates with a kinase complex that hyperphosphorylates CTD of RNAP II (identified thru an in vitro drug screen for Tat inhibitors)--this kinase is Cdk9, but Cdk9 does NOT bind Tat!? – Mystery human-specific co-factor for Tat activity must exist: Cyclin T Rev • Essential for nuclear export of unspliced or single spliced viral transcripts Ran-GTP RanGAP Ran-GDP Rev Ran GDP Importin-b Importin-b Arg Rich Domain (ARD) --binds to Importin-b for nuclear import Ran GTP Rev Ran-GTP Rcc1 Ran-GDP Rev Nuclear Export Signal (NES), leucine-rich domain, binds Exportin-1 (XPO) cooperatively with Ran-GTP Importin-b After nuclear import, Ran-GDP is converted to Ran-GTP, and importin- b dissociates from Rev “Free” ARD now can bind to RRE, but only in context of Rev multimers Nef • Major determinant of pathogenicity in vivo – nef-deleted SIV is severely attenuated in the rhesus macaque model – infection of macaques with recombinant SIV carrying a premature STOP codon (point mutation) results in rapid revertants with the nef ORF – Patients infected with nef-defective HIV have a dramatically decreased rate of disease progression (>15 years) – nef-deleted HIV do not deplete thymocytes as much, or replicate to as high titers, as wild-type HIV in the SCIDhu mice model Pleiotropic Functions of Nef N-myristoylation required for Nef activity--implies that membrane localization of nef is critical for its activity Consensus N-myristoylation Signal: MGxxx(S/T)(K/R)(K/R) MGxxx(S)(K)(K/R) HIV sequence Conservation in 99% 100% Nef protein: 100% ~50% Pleiotropic Functions of Nef • Down-regulates cell surface levels of CD4 • Down-regulates surface levels of major histocompatibility class I molecules • Mediates cellular signaling and activation • Enhances viral infectivity I. Down-modulation of surface CD4 • Down-modulation of surface CD4 via internalization followed by degradation via endosomal/lysosomal pathway • Advantages: – – • Prevents disadvantageous super-infection of host cell Enhance viral progeny release (by preventing Env-mediated sequestration of CD4 in secretory pathway) Evidence: – – – – Nef expression increases number of CD4 containing clathrin-coated pits Nef-induced CD4 down-modulation blocked by inhibitors of clathrin-coated pit-mediated endocytosis (e.g. ikaguramycin) Inhibition of lysosomal acidification (e.g. via chloroqine treatment) blocks Nef-induced CD4 degradation Expression of nef alone in T-cell lines can lead to CD4 downregulation (as determined by FACS) CD4 .. .................... ..................................... ... ........ ...................... ............................... . ............. ............... . ..... Nef-GFP I. Down-modulation of surface CD4 • Mechanism(s)? – Direct interaction with CD4 has not been biochemically demonstrable, but NMR analysis suggest a direct interaction with Kd ~0.87 mM; yeast two-hybrid assays also suggest an interaction – Acts as a connector to the host-cell endocytic machinery • Co-localizes with AP-2 on inner plasma membrane • Conserved dileucine based sorting motif (E/DxxxL ) in Nef is important for both CD4-downmodulation and AP-2 co-localization • Interacts with NBP-1 (identified through a yeast two-hybrid screen). NBP-1 is part of the vacuolar membrane ATPase complex in clathrin-coated pits (H subunit of vacuolar ATPase--VH1) • C-terminal diacidic motif (DD) in Nef is important for NBP-1 interaction, and, at least in SIV Nef, the dileucine motif is also important for NBP-1 interactions • ?? May bind to b-Cop, a coatamer protein which targets proteins to lysosomes NBP-1 II.Down-modulation of MHC Class I • Advantages: – Immune evasion; MHC Class I presents antigens to cytotoxic T- lymphocytes; alerts innate and adaptive immune system to virally infected cells • Evidence: – – – – Nef expression reduces susceptibility of HIVinfected cells to CTL mediated lysis in vitro selectively down-regulates only HLA-A and HLAB, which presents antigens to CTLs; does NOT down-regulate HLA-C and HLA-E, which inhibit NK-cell mediated cell lysis Thus, efficiency of CTL-mediated lysis (adaptive immunity) is reduced without increasing increasing susceptibility to NK cell lysis CTL HIV HIV antigen MHC Class I 51Cr 100% HIV Dnef HIV wt % Lysis E (Effector Cell) CTL 0% 1:2 1:5 1:10 E:T ratio 1:20 HIV antigen MHC Class I T (Target Cell) III. Mediates Cellular Activation and Signaling • Nef expression upregulates a transcriptional program that activates the HIV LTR (microarray analysis) III. Mediates Cellular Activation and Signaling • Nef expression upregulates a transcriptional program that activates the HIV LTR (microarray analysis) • Nef can induce secretion of paracrine factors that enhance viral replication; macrophage supernatants from cells transduced with nef-expressing adenoviral vector can facilitate HIV replication in resting lymphoid cultures Adv-nef supnt p24 (ng/ml) Adv-GFP supnt 3 6 9 (days) III. Mediates Cellular Activation and Signaling • Nef expression upregulates a transcriptional program that activates the HIV LTR (microarray analysis) • Nef can induce secretion of paracrine factors that enhance viral replication; macrophage supernatants from cells transduced with nef-expressing adenoviral vector can facilitate HIV replication in resting lymphoid cultures • Nef interacts with Pak2 (p21 activated kinase 2) and Nef/Pak2 complex may regulate many of Nef’s effect on gene transcription IV. Infectivity Enhancement • Magnitude of infectivity enhancement is allele dependent • Nef mediated enhancement can be provided in trans – reporter gene (e.g. GFP or luciferase) expression under control of the LTR promoter can be enhanced when nef expression vector is co-transfected • Mechanisms: – Increased RT activity; increased proviral DNA synthesis – Increased cytoplasmic delivery of viral particles Vpu: CD4 down-modulation 16 kDa, membrane spanning Binds CD4 tail in the ER Targets CD4 for proteolysis via ubiquitin-proteasome pathway Vpu mediated CD4 degradation via ubiquitin-proteasome pathway Evidence: Vpu activity disrupted by inhibitors of proteasomemediated proteolysis Vpu activity affected by dominant negative mutants of ubiquitin pathway Removal of lysine residues (ubiquination targets) in CD4 tail prevents Vpu-mediated degradation Vpu binds to b-TrCP, which in turns binds to the proteasome targeting factor Skp1p Overexpression of b-TrCP mutant that cannot bind Skp1p inhibits Vpu-mediated CD4 degradation Contrast with Nef Vpu: required for proper maturation and targeting of progeny virions, and for their proper release from the cell surface Oligomerization of its transmembrane domain results in ion channel activity Similar to influenza virus M2 protein, an ion channel protein that modulates the pH in the Golgi compartment Ion channel activity of Vpu may be required for proper virion maturation and assembly by protecting newly formed Env protein from premature conformational changes in the secretory pathway Vif: Viral infectivity factor, required for robust replication only in certain cells HIV-1 ( HIV-1 (Dvif) Hut78, H9, 1º PBLs C8166, 293T, HeLa Permissive Non-permissive +++ replication +++ replication +++ replication no replication Two hypotheses: (a) Permissive cells express an activity (factor) that can compensate for vif. (b) Non-permissive cells have an inhibitory activity on viral replication, which is overcomed by vif. See Simon et. al., Nature Med. 4: 1397 Non-permissive wt Dvif Permissive wt Dvif Heterokaryon wt Dvif Which phenotype will dominate? Non-permissive: inhibitory cellular factor overcomed by vif ++ - ++ Infectivity ++ Permissive: compensatory factor similar to vif Denv vs Denv/Dvif Non-Permissive Permissive vs Non-Permissive T Cell Line Two hypotheses: (a) Permissive cells express an activity (factor) that can compensate for vif. (b) Non-permissive cells have an inhibitory activity on viral replication, which is overcomed by vif. Permissive Permissive Heterokaryon Non-permissive wt ++ Dvif - Permissive wt ++ Infectivity wt Dvif ++ - Dvif ++ Non-permissive: inhibitory cellular factor overcomed by vif Expression of CEM15 in CEM-SS (permissive cells) renders it non-permissive Vpr: Two Independent Functions G2 Arrest LTR transcription, i.e.,virus production is more efficient during G2 Augments Nuclear Import of Pre-Integration Complex Extracellular vpr (from decaying virions, or cytosolic leakage from infected apoptotic cells) re-capitulates intracellular vpr function Induces cell cycle arrest Activates HIV replication in latently infected cells Increased HIV replication in macrophages Apoptosis; “bystander” cell killing in lymphoid organs and brain Vpr: G2 Cell Cycle Arrest “Quality Control” phase Mitosis is not initiated until DNA is free of damage G2 G2 Arrest LTR transcription is more active, i.e., virus production is more efficient during G2 S DNA Synthesis (Mitosis) M G0 G2 Arrest nuclear herniation due to disruption of nuclear lamin structure mixing of segregated cell cycle regulators may lead to G2 arrest G1 G2 + Vpr PO4- - M Wee1-GFP Cyc B1-RFP Vpr: Augments Nuclear Import of Pre-Integration Complex Vpr=Importin-b analog? Vpr lacks classical NLS sequences --but binds to Importin-a Vpr: Augments Nuclear Import of Pre-Integration Complex Importin-a Importin-a Transport of PICs containing Vpr-GFP fusion protein Red=anti-tubulin antibodies PIC/RTC Blue=anti-tubulin Green=Vpr-GFP Red=Alexa-dUTP Nuclear Import of PIC stalled by: (a)Anti-dynein Mab (b)Nicodazole treatment (nicodazole disrupts microtubles)